Evidence map›Paper›PMID 39338469›Full record

ArticleMicroorganisms2024

Chikungunya Virus RNA Secondary Structures Impact Defective Viral Genome Production.

Laura I Levi, Emily A Madden, Jeremy Boussier, Diana Erazo, Wes Sanders, Thomas Vallet, Veronika Bernhauerova, Nathaniel J Moorman, Mark T Heise, Marco Vignuzzi

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laura I LeviViral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France.ORCID 0000-0002-7421-3450
Emily A MaddenDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.ORCID 0000-0003-0209-914X
Jeremy BoussierViral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France.
Diana ErazoViral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France.
Wes SandersDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
Thomas ValletViral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France.
Veronika BernhauerovaViral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France.ORCID 0000-0002-5595-4579
Nathaniel J MoormanDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
Mark T HeiseDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
Marco VignuzziViral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France.

Funding

Molecular Biology of Viral Diseases Predoctoral Training GrantT32AI007419 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mark T Heise, CARY A MOODY · 1993 to 2026
$4.7M
Defining Functional RNA Structures in an Arthritic Alphavirus GenomeR21AI138056 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HEISE, MARK T, MOORMAN, NATHANIEL J · 2018 to 2019
$424k
DARPA DARPA Cooperative Agreement #HR0011-17-2-0023France's defence procurement agency (DGA) DGA PhD fundingNIAID NIH HHS R21 AI138056NIAID NIH HHS T32 AI007419NIH HHS NIH Grant R21 AI138056
6 · The paper itself

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne RNA virus that poses an emerging threat to humans. In a manner similar to other RNA viruses, CHIKV encodes an error-prone RNA polymerase which, in addition to producing full-length genomes, gives rise to truncated, non-functional genomes, which have been coined defective viral genomes (DVGs). DVGs have been intensively studied in the context of therapy, as they can inhibit viral replication and dissemination in their hosts. In this work, we interrogate the influence of viral RNA secondary structures on the production of CHIKV DVGs. We experimentally map RNA secondary structures of the CHIKV genome using selective 2'-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-MaP), which couples chemical labelling with next-generation sequencing. We correlate the inferred secondary structure with preferred deletion sites of CHIKV DVGs. We document an increased probability of DVG generation with truncations at unpaired nucleotides within the secondary structure. We then generated a CHIKV mutant bearing synonymous changes at the nucleotide level to disrupt the existing RNA secondary structure (CHIKV-D2S). We show that CHIKV-D2S presents altered DVG generation compared to wild-type virus, correlating with the change in RNA secondary structure obtained by SHAPE-MaP. Our work thus demonstrates that RNA secondary structure impacts CHIKV DVG production during replication.

Indexed as

chikungunya virusdefective viral genomeRNA secondary structureSHAPE-MaP

Identifiers

PMID39338469
PMCPMC11434300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.